A股異動 | 智光電氣漲停 粵芯半導體12英寸芯片生產線項目實現量產
智光電氣(002169.SZ)今日漲停,現報7.65元,暫成交3億元,最新總市值60.3億元。智光電氣昨晚發公告稱,公司投資認購廣州譽芯眾誠股權投資合夥企業(有限合夥)(以下簡稱“譽芯眾誠”)30%有限合夥人份額,譽芯眾誠持有廣州粵芯半導體技術有限公司(以下簡稱“粵芯半導體”)50%股權,公司間接持有粵芯半導體股權。粵芯半導體建設的12英寸芯片生產線項目(一期)已達到投產條件,並於9月20日實現量產。據悉,粵芯半導體生產包括微處理器、模擬芯片等,滿足物聯網、人工智能及5G等創新應用的模擬芯片與分立器件需求。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.